Tag

#AI drug discovery

11 articles

AI-designed drug appears to turn back the body's biological clock in early trial

An AI-designed drug called rentosertib has shown potential in reversing biological aging markers, according to a study in Nature Biotechnology. The drug, developed by Insilico Medicine, was tested on 42 patients and demonstrated promising results in early trials.

Sep 747

Why biological data matters more in AI drug discovery

GSK and Relation Therapeutics have formed a $110 million collaboration to generate large-scale biological datasets for AI drug discovery, emphasizing the critical role of high-quality data in advancing AI models.

Aug 352

An OpenAI researcher is leaving to build a $2bn AI drug startup that has no name yet

Learn how to analyze molecular structures and predict drug properties using Python and AI techniques, a foundational skill for AI drug discovery.

Jul 1547

tech

Chai Discovery raises $400M at $3.8bn as AI drug discovery moves from promise to deployment

Learn how to build molecular fingerprint generators using RDKit and Python, a fundamental technique in AI drug discovery pipelines.

Jul 1554

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Learn how artificial intelligence is revolutionizing drug discovery by helping scientists find new medicines faster and more efficiently than ever before.

Jul 1443

Insilico Medicine advances AI drug for IPF to Phase III trials

This article explains how AI-driven drug discovery works and why Insilico Medicine's advancement of an AI-discovered IPF treatment to Phase III trials represents a significant milestone in computational medicine.

Jul 764

science

Building a Scaffold-Split Random Forest QSAR Co-Scientist for EGFR Inhibitor Discovery Using ChEMBL, RDKit, SHAP, and BRICS

This article explains how a scaffold-split Random Forest QSAR model, combined with tools like ChEMBL, RDKit, SHAP, and BRICS, can autonomously identify and design novel EGFR inhibitors, demonstrating advanced AI applications in drug discovery.

Jul 6105

Takeda signs US$600M AI drug discovery deal with Insilico

Takeda has entered a $600 million AI drug discovery collaboration with Insilico Medicine, leveraging AI to accelerate early-stage drug development across multiple therapeutic areas.

Jul 366

SandboxAQ brings its drug discovery models to Claude — no PhD in computing required

This article explains how AI-powered drug discovery models work and why integrating them into accessible platforms like Claude represents a major breakthrough in pharmaceutical research accessibility.

May 18108

The company that built TikTok’s algorithm is now designing drugs for diseases pharma called undruggable

ByteDance's Anew Labs, known for building TikTok's recommendation algorithm, is now using AI to design drugs for previously 'undruggable' diseases.

May 2120

Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine

Learn how to use AI-powered tools for drug discovery by analyzing molecular structures and predicting drug properties using Python and machine learning.

Mar 29139